Linked Life Data

7848890

Source:http://linkedlifedata.com/resource/pubmed/id/7848890

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1995-3-16
pubmed:abstractText
The study investigated the therapeutic effect of single-agent IV weekly vinorelbine (Navelbine, Pierre Fabre Oncologie, Boulogne, France) a semi-synthetic vinca-alkaloid, in women who had received no prior treatment for advanced or metastatic breast cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
854-7
pubmed:dateRevised
2011-8-25
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy.
pubmed:affiliation
Hospital Clinico Universitario de Valencia, Spain.
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II